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 INTRODUCTION  
Hypertensive disorder complicates 5 to 10% of all pregnancies and together 
they form one member of the deadly triad along with haemorrhage and infection 
that contributes greatly to maternal mortality and morbidity rate. 
Pre eclampsia is a pregnancy specific syndrome characterized by new onset 
hypertension, Proteinuria usually after 20 weeks gestation. It is classified into 
severe and non severe types and in its extreme may lead to liver and renal failure, 
disseminated intravascular coagulation, seizures. Pre eclampsia and eclampsia are 
estimated to be responsible for approximately 14% of maternal deaths per year.[1] 
Despite its impact on maternal and child health, efforts to predict and 
prevent the disease have been disappointing. Numerous strategies have been shown 
to have little benefits. Because our understanding of the pathogenesis of this 
disease is incomplete, these preventive strategies were proposed based on 
pathogenetic hypothesis that did not withstand the test of time. 
       An increasing number of risk factors for pre eclampsia are associated with 
upregulation of systemic inflammation. Infection may be a risk factor capable of 
stimulating the cascade of inflammatory events associated with pre eclampsia.  In 
particular the recognition of pre eclampsia as inflammatory disease has helped 
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researchers focus again on the potential involvement of infections in the causation 
of pre eclampsia. 
Periodontal disease is a common oral infection, with prevalence ranging 
from 10-60%. A localized increase in the number and tissue invasion of certain 
bacteria, primarily Gram –negative organisms, causes persistent inflammation and 
destruction of the tissues supporting the teeth. Emerging evidence suggests that 
periodontal disease is also associated with systemic disease such as atherosclerotic 
cardiovascular disease and ischemic stroke, diabetes mellitus and erectile 
dysfunction. [2]  
Periodontal disease may burden pregnant women systemically with 
endotoxin, inflammatory cytokines, and oxidative stressors at the maternal–foetal 
interface (Contreras et al. 2006). Thus, it may be a vascular stressor that plays a 
role in the development of pre-eclampsia in pregnant women. Furthermore, there is 
ample evidence that periodontal bacteria frequently enter the circulation causing 
generalized bacteremia. [3] 
Infected periodontium can also be regarded as a reservoir for both microbial 
products and inflammatory mediators like PGE2, interleukins (ILs) and other 
cytokines. Local PGE2 and both local and systemic tumour necrosis factor-α  
(TNF-α) levels were increased in periodontitis [4].The proinflammatory cytokines 
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enter blood stream, reach maternal fetal interface, trigger or worsen maternal 
inflammatory response.[5] 
 Numerous studies suggest that periodontal disease as a source of subclinical 
and persistent infection, may induce systemic inflammatory responses that increase 
the risk of adverse pregnancy outcomes, early pregnancy loss, and preeclampsia 
[6] 
Therefore, understanding the initiating aetiologic factor may help to design 
preventive and therapeutic strategies properly. 
C-reactive protein (CRP) is an acute-phase reactant synthesized by the 
liver. It is a marker of systemic periodontal disease. CRP has been associated with 
adverse pregnancy outcomes, including preeclampsia, intrauterine growth 
restriction, and preterm delivery.[7] . 
Therefore, CRP might be a plausible mediator of the association between 
periodontitis and adverse pregnancy outcomes. 
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ETIOPATHOGENESIS OF PRE ECLAMPSIA 
According to National High Blood Pressure Education Working group 
(NHBPEP) and the American College of Obstetricians and Gynaecologists 
[8](ACOG) hypertension in pregnancy is defined as a diastolic blood pressure of 
90mmhg or a systolic blood pressure of 140mmhg or higher after 20 weeks 
gestation in a woman with previously normal blood pressure. (NHBPEP.2000; 
ACOG 2002).This is best confirmed when evidence is present on two occasions at 
least 6 hours apart but within 7days. 
Diastolic blood pressure is determined as the disappearance of sound 
(korotkoff  phase v).The blood pressure level should be taken with an appropriate 
size cuff with the patient in an upright position after a ten minute or longer rest 
period. It is taken whether the patient is sitting or in the left lateral recumbent 
position with the arm at the level of the heart. 
DIAGNOSIS OF HYPERTENSIVE DISORDERS COMPLICATING 
PREGNANCY 
1. GESTATIONAL HYPERTENSION 
         BP≥140/90 mmhg, no proteinuria, BP returns to normal before 12 
weeks postpartum. 
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2. PRE ECLAMPSIA/ ECLAMPSIA 
         BP≥140/90 mmhg after 20 weeks of gestation accompanied by 
proteinuria; eclampsia if seizures occur. 
3. PRE ECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION 
       New onset proteinuria in women with hypertension alone in early 
pregnancy before 20 weeks. 
A sudden increase in proteinuria or blood pressure or platelets count 
100,000/cu.mm in women with hypertension and proteinuria before 20 weeks 
gestation. 
4. CHRONIC HYPERTENSION 
  Hypertension before pregnancy or diagnosed before 20 weeks gestation 
does not resolve after 12 weeks postpartum 
PATHOGENESIS: 
Writings describing eclampsia have been traced as far back as 2200BC 
(Lindheimer and colleagues, 2009) and an imposing number of mechanisms have 
been proposed to explain its cause. Instead of being simply “one disease”, pre 
eclampsia appears to be a culmination of factors that likely involve a number of 
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maternal, placental, fetal factors. The exact etiology of pre eclampsia remains 
unknown. Several theories have been proposed over the years most of which have 
not withstood the test of time. As Boyd stated Pre eclampsia remains “die 
krankheit der theorien” –the disease of theories. [5] 
Some of the currently more accepted hypotheses include, 
1. Placental implantation with abnormal trophoblastic invasion of uterine     
vessels. 
In normal implantation endovascular trophoblasts replace the vascular 
endothelial and muscular linings of spiral arterioles to enlarge the vessel 
diameter. In pre eclampsia there may be incomplete trophoblastic invasion. 
Diminished perfusion and a hypoxic environment eventually leads to release 
of placental debris that incites a systemic inflammatory response.[9] 
2. Immunological maladaptive tolerance between maternal, paternal and 
fetal tissues. 
Loss of maternal immune tolerance to paternally derived placental and fetal 
antigens is another theory cited to account for pre eclampsia. Redman and 
colleagues (2009) postulated that early in pregnancy destined to be pre 
eclamptic, extravillous trophoblast express reduced amount of 
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immunosuppressive human leukocyte antigen (HLA-G) which may 
contribute to defective placental vascularization. [10]  
3. Maternal maladaptation to cardiovascular or inflammatory changes of 
normal pregnancy. 
Faas(2000) proposed that endothelial cell dysfunction is due to an extreme 
activated state of leukocytes in maternal circulation[11]. Briefly cytokines 
such as  tumor necrosis factor -α(TNF-α) and the interleukins (IL) may 
contribute to the oxidative stress associated with pre eclampsia.This is 
characterized by reactive oxygen species and free radicals that lead to 
formation of self propagating lipid peroxides. 
              The lipid peroxides in turn generate highly toxic radicals that injure 
endothelial cells, modify their nitric oxide production, and interfere with 
prostaglandin balance.Other consequences of oxidative stress includes 
production of the lipid laden macrophage foam cells seen in 
atherosis,activation of microvascular coagulation manifested by 
thrombocytopenia and increased capillary permeability manifest by edema 
and proteinuria.[12]    
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4. Genetic factors including inherited predisposing genes as well as epigenetic 
influences. 
 Ward and Lindheimer in 2009 [13 ] cited that an incident risk for pre eclampsia 
of 20 to 40% for daughters of pre eclamptic mothers;11 to 37 % for sisters of pre 
eclamptic women;    and 22 to 47% in twin studies. This hereditary predisposition 
may likely be the result of literally hundreds of inherited genes –both maternal and 
paternal – that control myriad enzymatic and metabolic functions throughout every 
organ system.  
RISK FACTORS 
 Extremes of age  
 Nulliparity 
 Obstetric 
• Multiple gestation 
• Hydrops fetalis 
• Hydatidiform mole 
 Pre existing medical disorders 
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• Hypertension 
• Diabetic mellitus 
• Renal disease 
• Autoimmune disease 
• Thrombophilias 
 Genetic 
 Family history 
 Smoking 
 Alcoholism  
Preeclampsia is best described as a pregnancy specific syndrome that can 
affect virtually every organ system. 
Minimum Criteria:  
BP≥ 140/90mmhg > 20weeks of gestation 
          Proteinuria ≥ 300mg/24hours or ≥ 1+dipstick 
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               INDICATORS OF SEVERITY OF PRE ECLAMPSIA 
 
Abnormality Non Severe Severe 
Diastolic BP  <110mg ≥110mg 
Systolic BP <160mg ≥160mg 
Proteinuria ≤ 2+ ≥3+ 
Headache  Absent Present 
Visual disturbance    Absent Present 
Upper abdominal Pain Absent Present 
Oliguria Absent Present 
Convulsion Absent Present 
Sr creatinine Normal  Elevated 
Thrombocytopenia Absent Present 
Sr transaminase Elevation  Minimal Marked 
Fetal growth restriction  Absent Obvious 
pulmonary edema Absent Present 
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PROTEINURIA:  
          Proteinuria is defined as excretion of ≥ 0.3mg protein in a 24 hour 
sample which correlates with >30 mg/l or >1+ dipstick in a random sample after 
excluding urinary tract infection.[5] 
Dipstick provides quick and simple standardized colour tests to detect 
protein. The strip is composed of stiff absorbent cellulose, one end of which is 
impregnated with the indicator “tetra-brom-phenol blue” and buffered to pH 3. 
The test end of the reagent strip has to be dipped in urine and taken out 
immediately. Any change in colour of the test end is compared with the colour 
chart provided by the manufacturer. 
Trace 0.1gm/L 
1+ 0.3gm/L 
2+ 1.0gm/L 
3+ 3.0gm/L 
4+ 10.0gm/L 
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ESTIMATION OF PROTEINURIA BY DIPSTICK 
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        PERIODONTAL INFECTIONS 
Periodontitis is an inflammation of the periodontium or one of the four 
tissues that support the teeth in the mouth. [14] 
• The gingiva 
• The cementum, or outer layer of the roots of teeth 
• The alveolar bone, or the bony sockets into which the teeth are 
anchored 
• The periodontal ligaments, which are the connective tissue fibres that 
connect the cementum and the gingiva to the alveolar bone. 
Periodontitis is a chronic oral infection characterized by gram negative 
bacteria.  The principal organisms implicated are 
1. P. Gingivalis 
2. F. nucleatum 
3. E.corrodens 
4. A.actinomycetumcomitants 
 
19 
 
HEALTHY PERIODONTIUM 
 
DISEASED PERIODONTIUM 
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MODERATE PERIODONTITIS 
 
SEVERE PERIODONTITIS 
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Symptoms of periodontitis 
• Bleeding gums 
• Suppuration of gums 
• Halitosis and mobility of teeth 
American Academy of Periodontology classification of the types of 
periodontal diseases [14] 
Type I: Gingival Diseases:  An inflammation or lesion of the gum 
characterized by changes of color, gingival form, position. 
Type II: chronic periodontitis:  An inflammation of the supporting 
structures of the teeth associated with plaque and calculus.  It can be further 
classified as localized or generalized 
Type III: Aggressive periodontitis:  characterized by a rapid rate of 
periodontal disease progression in an otherwise healthy individual in the absence 
of large accumulations of plaque and/or calculus. 
Type IV: Periodontitis as a manifestation of systemic disease 
Type V: Necrotizing periodontal disease:  Ulcerated and necrotic gums 
between teeth at the tooth margins 
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Type VI: Abscess of the periodontium: A localized pus forming infection of 
the periodontal tissue. 
Type VII: Periodontitis associated with endodontic lesions: Localized deep 
periodontal pocket extending to the tip of the root involving pulp death. 
Type VIII: Developmental or acquired deformities and condition: Gingival 
disease or periodontitis started by localized tooth related factors that modify or 
predispose to plaque accumulation. 
RELATIONSHIP BETWEEN PREGNANCY AND PERIODONTAL 
DISEASE 
Pregnancy, puberty, menstrual cycle and oral contraceptive pills all have 
been coupled with transient, self limiting periods of gingivitis. A common feature 
these conditions share is an elevation in the plasma concentration of estrogen and 
progesterone.  Data from numerous studies states that the ovarian hormones alter 
the micro environment of the oral bacteria so as to promote their growth and shift 
in their populations.  
Gingivitis in pregnancy is caused by bacterial plaque just as it is in non 
pregnant women. Pregnancy accentuates the gingival response to plaque and 
modifies the resultant clinical picture. 
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The aggravation of gingivitis in pregnancy has been attributed to the 
increased levels of progesterone, which produce [15]  
1. Dilation and tortuosity of the gingival microvasculature 
2. Circulatory stasis 
3. Increased susceptibility to mechanical irritation 
4. Leakage of fluid into perivascular tissue. 
 Kornman k, and Losechein 1980[16] found that during the second trimester 
gingivitis and ratios of bacterial anaerobes to aerobes increased. 
Lapp et al [17] suggests that high level of progesterone during pregnancy 
causes down regulation of interleukin-6 production, rendering the gingiva less 
efficient at resisting the inflammatory challenges produced by the bacteria. 
Gingival tissues return to their original healthy state postpartum when 
oestrogen and progesterone levels reach baseline values. Partial reduction in the 
severity of gingivitis occurs by two months postpartum and after one year the 
condition of gingiva is comparable to that of patients who have not been pregnant. 
In some women especially in those who have a pre existing gingival 
pathology, this simple gingivitis can progress to periodontitis.  
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Preeclampsia-? Infectious etiology: 
   Despite active research for many years the causes of pre eclampsia remains 
unknown. One of the most commonly proposed mechanisms is that endothelial 
dysfunction associated with preeclampsia may result from a generalized maternal 
intravascular hyper inflammatory state. 
  Acute atherosis, the placental lesion of pre eclampsia shares a similar pathology, 
pathogenesis, and clinical setting with atherosclerosis. Recently there is increasing 
evidence connecting chronic infection and the formation of atherosclerosis. [18] 
        Contreras et al reported that periopathogenic pathogens were more prevalent 
in the gingival crevicular fluid of pre eclamptic patients. [19] 
      The chronic inflammatory nature of periodontal infection and its possible role 
in the initiation of atherosclerosis, together with the pathological appearance of pre 
eclampsia (acute atherosis) are the basics for our hypothesis for a possible role of 
periodontal pathogens in the development of acute atherosis, the placental lesion of 
pre eclampsia. 
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PERIODONTITIS AND PREECLAMPSIA 
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Periodontal disease and maternal inflammatory response mechanism  
The biological mechanism to support a link between maternal periodontal disease 
and pre eclampsia involves micro-organisms in the oral cavity that may enter the 
bloodstream passively through the inflamed periodontal pocket wall or through 
invasive oral procedures. The maternal periodontal infection then influences 
fetoplacental unit in the following three ways [20,21]. 
1. Action of the proinflammatory mediators 
Periodontal disease are associated with chronic gram negative anaerobic 
infections resulting in local and systemic elevations of proinflammatory 
prostaglandins, including prostaglandin E2 (PGE2) and cytokines (IL-1, IL-6, and 
TNF-α).  
2. The action of the periodontal reservoir of bacterial lipopolysaccharides 
(LPS) 
The oral micro-organisms themselves are not directly implicated in the pre 
eclampsia. Rather, bacterial lipopolysaccharides (LPS) (endotoxin) stimulation 
occurs in response to localized non-disseminating substantaneous infection with 
porphyromonas gingivalis (a common periodontal pathogen). 
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It is said that these bacterial lipopolysaccharides (LPS) can mediate the 
release of fever inducing IL-1 (interleukin-1), TNF-α (tumor necrotic factor α) and 
the hepatic release of acute phase proteins such as C-reactive protein (CRP). LPS 
can also target the placenta to induce the placental production of IL-1 and IL-6 
resulting in inflammation of the placenta without reaching the fetal circulation. 
Production of IL-1, IL-6. TNF-α, CRP and secondarily PGE2 (prostaglandin 
E2) modulates placental blood flow and could result in Pre eclampsia.   
3. Direct assault of micro-organism on the fetoplacental unit 
This mechanism involves translocation of periodontal pathogens to the 
fetoplacental unit, through the blood. Thus Periodontitis leads to a cascade of 
events that involve systemic maternal inflammatory responses, as well as 
inflammation of the fetal-placental unit resulting in abnormal pregnancy outcomes.   
Periodontal disease and blood CRP levels 
 Periodontal disease being chronic and cyclic in nature provides an 
opportunity for repeated hematogenous dissemination of periodontal pathogens 
and direct microbial exposure of the vasculature, the liver and the placental-fetal 
unit among pregnant women. 
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 The organisms can easily ingress into the peripheral circulation by 
way of regular chewing or any dental manipulations such as brushing or flossing. 
The severity of the recurrent bacteremia is said to be the principal cause of the 
observed association between periodontal disease and increased serum CRP levels. 
Tillete and Francis in 1930 [22] were the first to discover the C Reactive protein 
an acute phase protein which is the primary response of the body to injury. 
 The C Reactive protein is so named because it forms a precipitate in a 
non-specific somatic reaction with the pneumococcal capsular polysaccharide in 
the presence of calcium ions. 
 In the body CRP can bind to a wide variety of substance derived from 
both damaged autologous cells and from micro-organisms. Complexed CRP can 
activate the complement system and thereby serves as a protective mechanism to 
the body.  
 Clinical measurement of CRP is valuable as a screening test for 
organic diseases and as an index for disease activity and response to therapy in 
certain inflammatory and ischemic conditions.  
 C - reactive protein (CRP) is synthesized by the liver in response to 
the inflammatory cytokines interleukin IL-6, IL-1, and TNFα tumor necrosis 
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factor-alpha [20]. Circulating CRP levels are a marker of systemic elevation of 
proinflammatory cytokines and prostaglandin. Interestingly, standard non-surgical 
periodontal therapy has been found to cause a decrease in serum CRP levels [23].  
Evidence supporting the association between periodontitis and CRP is based 
mainly on studies in men and non-pregnant women. There are very few studies of 
periodontitis and CRP in pregnant women. CRP has been associated with adverse 
pregnancy outcomes, including preeclampsia, intrauterine growth restriction, and 
preterm delivery. 
    Therefore, CRP might be a plausible biological/pathologic mediator 
of the association between periodontitis and adverse pregnancy outcomes [24]. 
Treatment of Periodontitis 
The therapeutic goals of periodontal therapy are [23] 
1. To alter or eliminate the microbial etiology and contributing risk factor for 
periodontitis, thereby arresting the progression of disease and preserving the 
dentition in a state of health, comfort, and function with appropriate 
aesthetics. 
2. To prevent the recurrence of periodontitis 
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3. Regeneration of the periodontal attachment apparatus, where indicated, may 
be attempted. 
  
REVIEW OF LITERATURE 
Miller in 1891 [24] published the theory of “focal infection”. On the basis 
of this theory, oral foci of infection were considered responsible for a number of 
regional and systemic diseases, such as tonsillitis, pneumonia, endocarditis and 
septicemia. However, the lack of scientific evidence condemned this theory to 
dormancy. 
It was 100 years later, in the early 1990s that Collins and colleagues [21] 
hypothesized that oral infection, such as periodontitis, could act as a source of 
bacteria and inflammatory mediators that could disseminate systemically to the 
feto-placental unit via the blood circulation and induce pregnancy complications. 
In a series of landmark animal studies in which pregnant hamsters were 
injected with the periodontal pathogen Porphyromonas gingivalis, Collins and 
colleagues [25] found that infection led to smaller fetuses (approximately 20 
percent reduction in weight) and to an increase of inflammatory mediators (TNF α 
and PGE2) at the site of infection and in the amniotic fluid. 
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In subsequent experiments, in which periodontal disease was induced in 
pregnant hamsters, the investigators found similar results in terms of fetal growth. 
These were the first proof-of-principle experiments to suggest a possible 
association of periodontal disease with adverse pregnancy outcomes. 
Three separate lines of evidence currently relate oral infection to pregnancy 
outcome:  
1. Microbiological studies,  
2. Case control studies,  
3. Prospective longitudinal studies. 
The first line of evidence to support a relationship between periodontitis and 
Pre-eclampsia is found in several microbiological studies of amniotic fluid, 
maternal and fetal cord serum, and gingival crevicular fluids (GCF). 
 Dr.Orit Oeltinger barak et al in 2005[26] reported findings of a one to one 
matched case control study (N=15) that evaluated the association between 
periodontitis and preeclampsia supported by immunological assessment of gingival 
crevicular fluid sample. Pre eclamptic group had higher probing depth and clinical 
attachment level compared with controls, (2.98 vs. 2.11 and 3.33 vs. 2.30 
respectively). Gingival crevicular fluid prostaglandin E2 (PGE2), tumor necrosis 
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factor (TNF) - α, and interleukin (IL)-1 β levels were also significantly higher in the 
pre eclamptic group. 
A.Contreras et al in 2006[19] conducted a case control study to determine the 
effect of periodontitis and the subgingival microbial composition on preeclampsia.  
A total of 83 out of 130 preeclamptic women (63.8%) and 89 out of 243 controls 
(36.6%) had chronic periodontitis (OR: 3.0; 95% confidence interval (CI): 1.91 to 
4.87; p<0.001) Prophyromonas gingivalis and Tannerella forsythensis, and the 
green complex microorganism Eikenella corrodens were more prevalent in the 
preeclamptic group than in controls (p<0.01)  
Shlomi Barak et al in 2007[27] conducted a study to explore the possibility of 
translocation of periopathogenic bacteria into the placental tissue of women with 
preeclampsia. Samples were taken from 16 placentas obtained from caesarean 
section. Eight of the 16(50%) placenta specimens were positive compared to only 
two of 14(14.3%) sample from controls. Bacterial counts were significantly higher 
in the preeclampsia group for all periopathogenic bacteria examined 
(P≤0.0055).This suggests the possible contribution of periopathogenic bacteria to 
the pathogenesis of pre eclampsia. 
Each of the above studies suggests that periodontal infection is a source of 
microbial products causing an inflammatory response that affects the pregnancy 
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outcome. The studies also suggest that maternal periodontal infections, resulting in 
blood borne microorganisms that can translocate to the fetus, provide a systemic 
challenge to the fetus and induce an immunological response. 
The second line of evidence comes from examining case control studies. 
Canacki V et al in 2004 [ 28] carried out an matched case control study on 41 pre 
eclamptic and 41 normotensive pregnant women to investigate the association 
between periodontitis and pre eclampsia .Results  showed that pre eclamptic 
women patients were 3.47(95%CI=1.07-11.95) times more likely to have 
periodontal disease. 
Cota et al in 2006 [29] conducted a case control study comprising of 588 antenatal 
women to determine the association of maternal periodontitis and risk of  pre 
eclampsia and found a statistically significant association between the two. 
(P=0.001 OR=1.88; 95%CI=1.1 to 3.0). 
Kunnen et al 2007[30] conducted a case control study to investigate the 
correlation between maternal periodontitis and early onset pre eclampsia in 
antenatal women with gestational age less than 34 weeks. Severe periodontal 
disease was found in 14 of 17(82%) pre eclamptic women and 13 of the 35(37%) 
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women in the control group. There was significant correlation between early onset 
pre eclampsia and severe periodontal disease. 
Fernanda mafro siqueira et al in 2008[31] conducted a case control study on 
1206 Brazilian women divided into a control group(1042 non pre eclamptic) and a 
case group(164 pre eclamptic).Further 125 pre eclamptic women were matched to 
non pre eclamptic women randomly selected from the control group. After 
controlling for confounders, maternal periodontitis remained associated with 
preeclampsia (OR = 1.52; 95%, CI: 1.01 – 2.29; P=0.045) emphasizing the 
importance of periodontal care in prenatal programs. 
The third line of evidence comes from prospective studies, 
Dr. Michael S. Rumo et al in 2002[32] conducted a cohort study with 775 healthy 
pregnant women who had oral examinations and C-Reactive Protein (CRP) level 
measured at enrollment (<26 weeks gestation) and found women with periodontal 
disease and CRP ≥75th percentile were at increased risk for pre eclampsia (adjusted 
RR5.8, 1.2 – 26.9) Compared to women without periodontal disease and either 
CRP <75th or ≥75th percentile 
Boggess KA et al [33 ] conducted a large prospective study with a cohort of 1115 
pregnant women to determine the association of maternal periodontal disease with 
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development of pre eclampsia.Women were at higher risk for pre eclampsia if they 
had severe periodontal disease at delivery (OR=2.4.95%CI=1.1-5.3) or if they had 
periodontal disease progression during delivery (OR=2.1, 95%CI=1.0-4.4). 
Amanda L. Horton et al in 2010[34] conducted a prospective study to determine 
the relationship among maternal periodontal disease, maternal oxidative stress, and 
the development of preeclampsia. They analyzed maternal blood for 8- isoprostane 
concentrations using enzyme linked immunosorbent assay and women with an 8 – 
isoprostane concentration ≥75th percentile (38.2% versus 24.4%, p=0.07, OR: 1.91; 
95% confidence interval (CI: 0.94 to 3.90) were at increased risk for developing 
preeclampsia.   
Canaki V et al in 2007[35] conducted a study on 59 pregnancy women (20 mild 
pre- eclampsia, 18 severe pre eclampsia, 21 healthy pregnant women) to evaluate 
the possible link between the severity of periodontal disease and pre eclampsia and 
to correlate this link to clinical periodontal parameters and IL–1, TNF α, PGE2 
levels in both gingival crevicular fluid and serum. 
      After adjusting for the confounding factors, severe pre eclamptic women were 
3.78 times more likely to present severe periodontal disease than normotensive 
pregnant women. IL–1, TNF α, PGE2 levels in both serum and GCF were also 
significantly higher in the pre eclamptic groups than normotensive. 
36 
 
Luis O. Rustveld et al [36] conducted a systematic review in which sixteen of the 
32 studies were selected for inclusion in the meta-analysis.  These studies showed 
any infection (bacterial or viral) was associated with a twofold higher risk of 
preeclampsia.  This association may provide a potential explanation for pre-
eclampsia related inflammation (combined results for the 16 studies yielded an OR 
of 2.1 (95% CI 1.6 – 2.7). 
Agustin condo – Agudelo et al in 2008[37] in a systematic review conducted on 
49 observational studies examined the relationship between maternal infection and 
preeclampsia.  The risk of pre eclampsia was increased in pregnant women with 
urinary tract infection (pooled odds ratio: 1.57; 95% CI: 1.45 – 1.70) and 
periodontal diseases (pooled odds ratio: 1.76; 95% CI: 1.43 – 2.18). 
Periodontitis and C Reactive Protein 
Tilette and France in 1930[22] were the first person to discover the C Reactive 
protein which is an acute phase protein produced by the body in response to injury. 
M.B Pepys in 1981[22] proposed that an elevated serum concentration of CRP is 
an evidence of active tissue damaging processes and measurement of levels forms 
a screening test for organic diseases and inflammatory states. Increased CRP levels 
37 
 
were also a very early and sensitive response to different forms of microbial 
infections.  
Ebersole et al in 1977 [38]compared the levels of both CRP and haptoglobulin in 
the serum of adult with periodontitis and in normal subjects using ELISA and 
found that both were elevated in the sera of adults with periodontitis. Statistically 
significant decrease in the values occurred after the treatment of periodontitis. 
Noack et al in 2001 [39] examined the levels of CRP in patients with periodontitis 
and correlated it to the severity of periodontal disease and to periodontal micro 
flora. Results obtained showed that the extent of increase in CRP levels in patients 
depends on the severity of the disease after adjusting for age, body mass index and 
smoking.   
    The sub gingival plaque samples were then examined for the presence of 
bacteria known to cause periodontitis by immnuoflourescence microscopy. 
Presence of periodontal pathogens was positively associated with elevated CRP 
levels.                                                                                                                                                                 
In 2006 Waranuch Pitiphat et al [40] conducted a cohort study, where they 
measured plasma CRP in 35 subjects with periodontitis (i.e., at least one site with 
≥3mm of alveolar bone loss) and a random sample of 66 periodontally healthy 
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subjects matched on age and race/ethnicity. The mean CRP level was 65% higher 
(95% confidence interval: -2%, 180%; P=0.06) in women with periodontitis (2.46 
± 0.52 mg/l) than in controls (1.49  ± 0.22 mg/l), after adjusting for factors related 
to CRP levels, including age, race/ethnicity, pre-pregnancy body mass index, 
alcohol intake, education, income, and gestational age at blood collection.  
J Herrera et al in 2007[41 ] investigated the effect of the severity of periodontal 
diseases, subgingival microbial composition and serum hs-c-reactive protein levels 
in preeclampsia women.  He found periodontal infection with E Corrodens in all 
women (n-167) was associated with higher levels of hs-CRP (median 6.34 mg/dl) 
compared with subjects not infected with the bacteria (n -231 median 5.32 mg/dl) 
(p<0.05) . 
Recently Amanda et al in 2008 [42] conducted a study in African American 
pregnant women and concluded that moderate/severe periodontal diseases were 
significantly associated with elevated CRP levels (adjusted OR: 4.0; 95% 
confidence interval [CI]: 1.2 to 8.5).  
All the above studies suggest that periodontitis may increase CRP levels in 
pregnancy. CRP could potentially mediate the association of periodontitis with pre 
eclampsia and other adverse pregnancy outcomes.  
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AIM OF STUDY 
1) To identify the association between maternal periodontitis, maternal 
systemic inflammation and preeclampsia.  
2) To investigate whether C - reactive protein is the possible mediator of the 
association between periodontitis and pre eclampsia.  
 MATERIALS AND METHODS 
Study Population  
 The study is a prospective cohort study conducted from May 2009 – October 
2010 among antenatal primi booked at Institute of social obstetrics and Govt. 
Kasturba Gandhi Hospital. Over this period, eligible healthy women with a 
singleton pregnancy were enrolled at <20 weeks gestation and followed till 
delivery for the development of pre eclampsia. Demographic information, health 
behavior and medical history data were obtained by patient interview and 
questionnaire at the first visit. Periodontal examinations were performed at 
enrollment and within 48 hours of delivery to determine the presence of 
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periodontal disease or periodontal disease progression. Maternal blood was 
collected at enrollment for estimation of C-reactive protein. 
                    Gestational age was calculated by the date of the last menstrual period 
and was confirmed by a first or second trimester ultrasound examination. Details 
on the course of the labour, delivery and new born were abstracted from the 
medical record. During the period of study a total 200 antenatal women were 
included in the study. A written consent was obtained before their enrollment. 
A detailed general examination and a meticulous local examination were 
performed. 
 INCLUSION CRITERIA 
  Primi gravida between 18 to 35 years  
  Women with singleton live Pregnancy 
EXCLUSION CRITERIA 
 Multiple gestation 
 Chronic hypertension 
 Diabetes 
  Renal disease 
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  Heart disease 
  Infection requiring antibiotic 
 Obesity 
 Current use of corticosteroids 
 Presence of fetal congenital anomalies 
The patients were subjected to a speculum examination to note the presence of 
any abnormal discharge. A drop of potassium Hydroxide was added to the 
secretion and the development of a fishy odour was taken as a positive test for 
Bacterial vaginosis. These patients were excluded from the study. 
Urine was collected in a sterile container and sent to the microbiology lab 
where culture was done. Those with Urinary tract infection were also excluded 
from the study. 
Pre eclampsia categorized as 2 episodes of blood pressure >140/90 mmhg and 
atleast 1+proteinuria in urine sample. 
    Maternal serum assayed for C-REACTIVE PROTEIN and stratified . 
Periodontal Examination  
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Study participants underwent an intra-oral examination by a qualified 
periodontologist at enrollment and within 72 hours postpartum. The examination 
was carried out using a mouth mirror and William’s graduated periodontal probe. 
Periodontal Evaluation   The probing depth and the clinical attachment loss 
(CAL) were the parameters that were measured. 
 
MOUTH MIRROR & WILLIAMS GRADUATED PERIODONTAL PROBE 
(with mm markings) 
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DETERMINATION OF PROBING DEPTH USING 
WILLIAMS PERIODONTAL PROBE 
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Probing Depth 
The distance in mm from the cemento-enamel junction to pocket base was 
defined as probing depth.  At least 6 areas of each tooth (buccal-mesial, mid-
buccal, buccal-distal, lingual-mesial, mid-lingual and lingual-distal) was examined 
using the periodontal probe. The highest score in mm for any tooth was recorded 
for probing depth.  
Clinical Attachment Loss (CAL)  
 Attachment loss is a more accurate measure of disease severity than 
probing depth and is defined as the distance in mm between the cemento-enamel 
junction and the base of the periodontal pocket. CAL was first calculated for each 
tooth separately. The mean CAL value was then computed. 
 Periodontitis was classified as localized or generalized depending on 
whether <4 or ≥ 4 sites showed a probing depth of > 3 mm and CAL >1 mm.  
Severity of periodontitis was classified as follows (AAP 1999): 
 Periodontal health was defined as CAL<1 mm 
 Mild periodontitis-CAL in the range of 1.1 – 2.9 mm 
 Moderate periodontitis-CAL in the range of 3-5 mm 
 Severe periodontitis-CAL>5 mm 
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In our study we have grouped patients with Periodontitis into two categories 
namely localized and generalized which is similar to the study conducted by 
Nabet C et al (2010)[43]. 
Biochemical investigations 
5ml of blood was drawn from every subject for routine investigations and 
also for estimation of C – Reactive protein (CRP) levels. 
Estimation of C – Reactive Protein by Nephelometry 
Principle 
Polystyrene particles coated with monoclonal antibodies specific to human 
CRP are aggregated when mixed with samples containing CRP. These aggregates 
scatter a beam of light passed though the sample. The intensity of the scattered 
light is proportional to the concentration of the relevant protein in the sample. The 
result is evaluated by the comparison with a standard of known concentration. The 
assigned value of CRP in CN Rheumatology standard SL is standardized against 
the interaction reference preparation BCR-CRM 470. 
 Composition 
Cardiophase hsCRP reagent consists of a suspension of polystyrene particles 
with monoclonal antibodies to CRP. 
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Armamentarium 
 BN System 
 Cardiophase hsCRP reagent 
 Five vials containing 5ml each of three vials. 
 N Rheumatology standard SL 
 N/T Rheumatology controls SL/1 and SL/2 
 Apolipoprotein  
 N supplementary reagent/precipitation 
 N Diluent 
Procedure 
1. Allow reagents and samples to equilibrate to room temperature before 
use on the instrument. 
2. On the instrument, samples should run at approximately the same 
ambient temperature (Maximum 3° deviation) as the measurements used for 
recording the reference curve.  
Assay Protocols 
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 The assay protocols, for serum as well as plasma, are given in the instruction 
manual and software of the instrument. All steps are performed automatically by 
the system. 
Establishment of Reference Curves 
 Reference curves are generated by multi-point calibration. Serial dilutions of 
N Rheumatology standard SL are automatically prepared by the instrument using 
N Diluent. The standard dilutions are to be used within four hours. The reference 
curve is valid for four weeks and can be used beyond this period of time, as long as 
controls with corresponding SL/1 and SL/2 or Apolipoprotein Control Serum CHD 
are reproduced within their respective confidence interval. If a different lot of 
reagent is used, a new reference curve must be generated. The exact measuring 
range depends upon the concentration of the protein in which lot of N 
Rheumatology Standard SL. 
Assay of specimens 
 Samples are automatically diluted 1:400 (CRPI) or 1:30 in the Cardiophase 
hsCRP assay protocol (CRP2) with N Diluent. The Diluent samples must be used 
within four hours. If the results obtained are outside the measuring range, the assay 
can be repeated using a higher or lower (only in the CRP1 assay protocol) dilution 
of the sample.  
Results 
The results are evaluated automatically by the analyzer and are represented 
in mg/L or in a unit selected by the instrument.  
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INSTRUMENT USED FOR CRP ESTIMATION 
 
KIT FOR CRP ESTIMATION 
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RESULTS 
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AGE DISTRIBUTION  
 
(Table 1) 
 
Sr. NO 
Age in 
Years 
Periodontitis Present Periodontitis Absent 
Number Percentage Number Percentage 
1 ≤ 20 26 28.26% 21 19.44% 
2 21-25 41 44.57% 49 45.37% 
3 26-30 22 23.91% 34 31.48% 
4 31-35 2 2.17% 4 3.70% 
5 >35 1 1.09% - - 
 
P value >0.05  Not Significant  
 
The average child bearing age in both groups was 23 years. 
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SOCIO ECONOMIC STRATA DISTRIBUTION 
(Table 2) 
 
Sr No 
Socio Economic 
Group 
Periodontitis Present Periodontitis Absent 
Number  Percentage Number  Percentage 
1 Class III 0 0 6 5.50% 
2 Class IV 10 10.86% 18 16.67% 
3 Class V 82 89.13% 84 77.78% 
 
 
      P value >0.05  Not Significant 
      Both groups have similar socio economic stratum.   
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ASSOCIATION BETWEEN PERIODONTITIS & PRE 
ECLAMPSIA 
(Table 3) 
 
Sr No Periodontitis 
Pre eclampsia Present Pre eclampsia Absent 
Total Number  Percentage Number  Percentage 
1 Present 15 16.30% 77 83.70% 92 
2 Absent 5 4.63% 103 95.37% 108 
  Total 20   180   200 
 
Chisquare value: 6.28 
P value < 0.05  Significant  
15 Antenatal women out of 92 women with periodontitis developed preeclampsia 
and only 5 out of 108 periodontally healthy women developed preeclampsia. This 
was statistically significant. 
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PERIODONTITIS ABSENT 
 
 
PERIODONTITIS PRESENT 
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ASSOCIATION BETWEEN PERIODONTITIS & PRE 
ECLAMPSIA 
(Table 4) 
 
Sr No Pre eclampsia 
Periodontitis Absent Periodontitis Present 
Number Percentage Number Percentage 
1 Absent 103 95.40% 77 83.70% 
2 Present Nonsevere 5 4.60% 9 9.78% 
3 Present Severe - - 6 6.52% 
 
P value < 0.05  Significant 
There is significant statistical association between Periodontitis and Pre eclampsia 
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ASSOCIATION BETWEEN PERIODONTITIS & PRE 
ECLAMPSIA 
(Table 5) 
 
P value < 0.05  Significant 
All 6 women with severe pre eclampsia had generalized periodontitis, and out of 
14 women with non severe pre eclampsia, 5 had localized periodontitis, 4 had 
generalized periodontitis and 5 women had healthy periodontium.  
PERIODONTITIS 
PRE ECLAMPSIA 
Total 
Absent Present Nonsevere Present Severe 
Number Percentage  Number Percentage  Number Percentage  
Absent 103 57.22% 5 35.71% - - 108 
Present Localized 49 27.22% 5 35.71% - - 54 
Present Generalized 28 15.56% 4 28.57% 6 100% 38 
Total 180 14 6 200 
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C-REACTIVE PROTEIN (CRP) LEVELS 
(Table 6) 
 
Sr No 
CRP Level in 
mg/l 
Periodontitis Present Periodontitis Absent 
Number Percentage Number Percentage 
1 <1 0 1.10% 61 55.56% 
2 1−2 24 25% 47 44.44% 
3 2−3 31 33.70% - - 
4 3−4 20 21.73% - - 
5 >4 17 18.47% - - 
 
P value <0.05  significant 
Levels of CRP were greater in women with Periodontitis compared to women with 
healthy periodontium. 
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COMPARISON OF CRP LEVELS WITH PERIODONTITIS 
(Table 7) 
 
Periodontitis CRP level in mg/l 
Absent (n=108) 0.89 
Present Localized (n=54) 2.05 
Present Genaralized (n=38) 3.92 
 
P value <0.05  significant 
The CRP levels were seen to increase with increasing severity of periodontitis. On 
applying the anova and post-hoc test, this was found to be statistically significant.   
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GESTATIONAL AGE AT DELIVERY 
(Table 8) 
 
Periodontitis Mean gestational age at delivery in weeks 
Absent (n=108) 38.71 
Present (n=92) 35.78 
 
P value <0.05  significant 
The Mean gestational age at delivery was 35.78 weeks in women with               
Periodontitis and 38.71 weeks in women without Periodontitis. 
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CORRELATION BETWEEN PERIODONTITIS AND 
GESTATIONAL AGE AT DELIVERY 
 (Table 9) 
Periodontitis Mean gestational age at delivery in weeks 
Absent (n=108) 38.7 
Present Localized (n=54) 36.7 
Present Generalized (n=38) 34.4 
 
P value < 0.05 Significant 
On applying the anova and post-hoc test, this was found to be statistically 
significant.   
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CORRELATION BETWEEN DEGREE OF PERIODONTITIS, 
GESTATIONAL AGE AT DELIVERY AND CRP LEVELS  
(Table 10) 
 
Periodontitis 
Mean gestational age at 
delivery in weeks CRP level in mg/l 
Absent 39 0.89 
Present Localized 36.7 2.05 
Present Generalized 34.4 3.92 
 
With increase in the severity of periodontitis there was a corresponding increase in 
CRP level and a decrease in the gestational age at delivery. 
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BIRTH WEIGHT DISTRIBUTION 
(Table 11) 
 
Sr No 
Birth 
weight (kg) 
Periodontitis Present Periodontitis Absent 
Number  Percentage Number  Percentage 
1 <2 6 6.52% 0 - 
2 2.1-2.5 35 38.04% 9 8.33% 
3 2.6-3 46 50% 35 32.41% 
4 3.1-3.5 5 5.43% 55 50.93% 
5 ≥3.6 0 - 9 8.33% 
 
P value <0.05  Significant 
The babies of the mothers with Periodontitis weighed relatively less than babies 
of mothers without Periodontitis.    
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COMPARISON OF BIRTH WEIGHT AND PERIODONTITIS 
(Table 12) 
 
Periodontitis Count Mean Birth weight  (kg) 
Absent 108 3.09 
Present 92 2.55 
 
P value <0.05  Significant 
The average birth weight of babies born to mothers with periodontitis was 3.09kg 
whereas those without periodontitis was 2.55kg 
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COMPARISON OF BIRTH WEIGHT 
(Table13) 
 
Periodontitis Mean Birth weight  (kg) 
Absent (n=108) 3.11 
Present Generalized (n=38) 2.35 
Present Localized (n=54) 2.69 
 
 P value <0.05  Significant 
 
The birth weights of babies in women with periodontitis were seen to decrease 
with increasing severity of periodontitis.  
On applying the anova and post-hoc test, this was found to be statistically 
significant.   
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DISCUSSION AND ANALYSIS 
.           Periodontitis is characterized by exacerbation periods interspersed with 
periods of remission and presents a local microbial burden that initiates local 
inflammation and local tissue destruction. 
   Women with active periodontal disease during pregnancy have transient 
translocation of oral bacteria to the maternal and fetal blood circulation inciting 
placental inflammation or oxidative stress early in pregnancy which ultimately 
produce placental damage and the clinical manifestation of pre eclampsia.   
          The number of antenatal women originally interviewed and examined for the 
study was 259 out of which 25 were excluded due to the presence of vaginal / 
cervical infections, 20 were excluded as they had urinary tract infection and 14 
were excluded as they had delivery in non study site. Finally 200 women were 
recruited for the study. 
                The mean age of the women in this study was 23 years which was 
similar to the study conducted by Contreras et al in 2006[19 ] in which it was 24 
years. 
 In this study 23% of the population was in ≤ 20 age group 45% in the age 
group of 21-25, 28% in the group from 26-30, 3.5% in the age group of 31-35 
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years. Though extremes of age are risk factors for pre eclampsia relatively fewer 
belonged to these age groups in the study. 
The maximum number of patients was in the 21-25 years age group. This 
represent the average child bearing age of the women in our country. 
 Among women with Periodontitis 10.86% of women belong to class IV, 
89.13% of women belonged to class V. In periodontally healthy women 5.50% of 
women belonged to class III, 16.67% of women belonged to class IV and 77.78% 
of women belonged to class V. Both groups had similar social economic strata 
distribution and there wasn’t significant difference between them. 
 Over the years in the various studies linking Periodontitis and pre eclampsia 
a wide array of definitions have been used to describe and quantify the severity of 
Periodontitis.  
The periodontal examination was performed at enrollment and within 48 
hours of delivery to determine the presence of severe periodontal disease or 
periodontal disease progression. It coincide with the study conducted by Boggess 
KA et al in 2008[32 ].   
 Offenbacher et al in 1996[44] stated that Periodontitis corresponded to an 
average clinical attachment loss (CAL) of ≥3mm at ≥60% of the examined site. 
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  Lopez et al in 2002[45] similar to our study examined all the teeth that were 
present in the dental arch and considered those antenatal women who had at atleast 
four site with probing depth ≥4mm and clinical attachment loss ≥3mm to be 
suffering from periodontitis. 
 Table [no. 3] shows that among the 92 antenatal women with periodontitis 
15 (16.3%) developed preeclampsia and out of 108 antenatal women without 
Periodontitis only 5 (4.6%) developed preeclampsia. The association was 
statistically significant with a p value < 0.05. 
 As shown in table 5, out of 14 women with nonsevere pre eclampsia 5 
(35.71%) had localized periodontitis, 4(10.53%) women had generalized 
Periodontitis and 5(35.71%) women were periodontally healthy. All six (100%) 
women with severe pre eclampsia had generalized Periodontitis. 
 Out of 180 normotensive women, 103(57.22%) had normal periodontium, 
49(27.22%) had localized Periodontitis and 28(15.56%) had generalized 
Periodontitis. The association between degree of Periodontitis and severity of pre 
eclampsia was statistically significant with a p value < 0.05.  The results of the 
present study showed that Antenatal women with periodontitis have 3.52 (95% CI 
= 1.33 – 9.32) times increased risk of developing pre eclampsia.  
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 The association is  in concordance with studies carried out  in Turkey   
(Canaki et al in 2004 )[28],  in Colombia ( A.Contreras et al 2006)[19], Turkey 
(Canakci et al 2007)[35], North carolina (Boggess et al 2003)[33], and Brazil 
(Fernanda et al 2008)[31], with ORs varying between 1.94 and 3.78.  
 Michael Ruma et al in 2008[46] conducted a Cohort study on 775 healty 
pregnant women who had oral examinations and C-reactive protein levels 
measured at enrollment (<26 weeks) and found that pre eclampsia was more 
common in those with high CRP alone (OR 2.6) and those with moderate to severe 
periodontal disease alone (OR 2.0), but a combination of high CRP levels and 
moderate to severe periodontal increased the odds ratio to 7.0   
 As shown in table 6, the C- reactive protein levels were higher in patients 
with periodontitis. The mean CRP level was 0.89mg/l in antenatal women without 
periodontitis and 2.82mg/l in those with periodontitis. It was found to assume 
statistical significance with a P value of <0.05 [Table 7]. 
 This was consistent with the study conducted by Dr. Pitiphat et al in may 
2006[47] where the median CRP level was 2.23mg/l (interquartile range 0.74 - 
4.14) in pregnant women with periodontitis and 1.46mg/l (interquartile range 0.71 
– 35.8) in those with no periodontitis. 
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 As has been previously quoted evidence supporting the association between 
Periodontitis and CRP is based mostly only on studies in men and non-pregnant 
women. There are only a few studies of Periodontitis and CRP in either pregnant or 
post-natal women. This is an important area for study because systemic 
inflammation plays a major role in the pathogenesis of pre eclampsia. CRP might 
be a plausible mediator of the association between Periodontitis and adverse 
pregnancy outcome.   
 As shown in table 7, The CRP levels were found to increase with increasing 
severity of Periodontitis. In the present study those with generalized periodontitis 
had the highest elevation of CRP 3.92mg/l (95% CI- 3.8 – 4.05). The one with 
localized periodontitis had a mean value of 2.05mg/l (95% CI- 1.95 – 2.15). The 
high CRP level seen in severe periodontitis could well be the cause for pre 
eclampsia in antenatal women. 
 As seen in table [8], the mean gestational age at delivery in antenatal women 
with periodontitis was 35.78 weeks and 38.71 weeks in women without 
periodontitis. 
 Further more in the present study the gestational age at delivery was found 
to be inversely proportional to the degree of periodontitis. In those with localized 
periodontitis, the mean gestational age at delivery was 36.7 weeks (95%CI= 36.43 
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– 36.98)  and  it was 34.7 weeks in case of  women with generalized periodontitis 
(95% CI= 33.99 – 34.98). It was found to be assume statistical significance with a 
P value of <0.05 [Table 9]. 
 The results of the present study showed that an antenatal woman with 
Periodontitis have 4.09 [RR=4.09, 95%CI(2.98-5.60) times increased risk of pre 
term labour. This association is in concordance with that which was originally 
suggested by Offenbacher et al in 1996 [44]and confirmed in further studies 
carried out in United States (Offenbacher et al 1998)[48], Chile (Lopez et al 
2002)[45], Thailand (Dasanayake et al 1998) [46]and Hungary (Radnai et al 
1998)[47s], with ORs varying between 3.5 and 7.9. 
 Thus, until recently only cervical / vaginal infections were thought to be 
capable of triggering inflammatory reactions leading to preterm labour. Data now 
supports the hypothesis that an inflammatory response to distant infectious foci 
like Periodontitis is also capable of causing preterm labour.  
As shown in Table[11] among antenatal women without periodontitis 8.3% 
of the babies weight between 2.1-2.5kg, 32.41% of the babies had weight in the 
range of 2.6-3, 50.93% of the babies had birth weight between 3.1-3.5kg and 
8.33% had birth weight >3.5kg.  
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Among antenatal women with periodontitis 6.52% of the babies had birth 
weight <2kg, 38.04% of the babies had weight in the range of 2.1 – 2.5 kg. 50% of 
the babies’ weight between 2.6-3kg and 5.43% of the babies had weight in the 
range between 3.1-3.5kg. 
As shown in Table [12], in antenatal women with periodontitis the mean 
birth weight was 2.55kg and in antenatal women without periodontitis it was 
3.09kg.  
It was also seen that the mean birth weight also decrease with increasing 
severity of periodontitis. In generalized periodontitis group the mean birth weight 
was 2.35kg (95% CI-2.25 – 2.46) and in the localized group the mean birth weight 
was 2.69kg (95% CI – 2.6-2.75). The values were most significant for generalized 
Periodontitis with the P value well below 0.05. This agrees with the previous 
studies which shown an inverse relationship between Periodontitis and birth weight 
[Table 13].  
In conclusion women with maternal periodontal disease and systemic 
inflammation early in pregnancy as measured by C-reactive protein are at 
increased risk for the development of pre eclampsia. Larger, more controlled, 
randomized trials are needed to conclusively prove these links and additional 
intervention studies are necessary to sdemonstrate the potential systemic benefits 
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of periodontal therapy so that periodontal therapy may be considered a vital part of 
prenatal case in pre-eclamptic patients in near future. 
These findings indicate that it is in the patient’s best interest to include 
periodontal evaluation as a part of obstetrical and pre-natal care. Individuals with 
significant pathology could then be offered treatment likely to reduce the incidence 
of pregnancy complications. Furthermore oral health could be included in pre 
conceptional conselling so that a lady could begin her pregnancy with a lower risk 
for pre eclampsia.  
For the majority of individuals affected with Periodontitis, the condition is 
symptom-free until the disease is more advanced. Therefore there is the need for 
medical personnel to increase the awareness among pregnant women [36]. The 
American Academy of periodontology recommends that every woman be referred 
for an oral examination early in pregnancy. The obstetrician should question every 
woman on symptoms of Periodontitis such as bleeding or swollen gums. 
Importantly, the present study also provides evidence to support collaborative 
initiatives among health care providers in medicine and dentistry. 
This approach may allow for pregnant women with elevated CRP levels to 
be classified as “high risk”, and thus evaluated more carefully for evidence of 
adverse oral health and pregnancy outcomes. 
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Thus both dentists and obstetricians have an obligation to collaborate and 
co-ordinate efforts to deliver adequate care for women of child bearing age. This 
transdisciplinary approach though presents unique challenges would reap rich 
dividends if implemented. 
Summary and Conclusion 
The study concludes that there is a significant association between 
periodontitis and pre eclampsia. Antenatal women with periodontitis have 3.52 
times increased risk of developing pre eclampsia. 
The presence and severity of periodontal disease seems to increase the risk 
for not only the occurrence but also the severity of pre eclampsia in pregnant 
women. 
The CRP was found to be elevated in antenatal women with Periodontitis 
when compared to those women who were periodontally healthy. The presence of 
generalized Periodontitis was associated with lower gestational age at delivery and 
lower birth weight when compared to presence of localized Periodontitis. 
There was significant correlation between increased CRP level, increasing 
severity of Periodontitis and pre eclampsia. This study also suggests that CRP 
could be the biologic mediator between the Periodontitis and pre eclampsia. 
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In conclusion women with maternal periodontal disease and systemic 
inflammation early in pregnancy as measured by C - reactive protein are at 
increased risk for the development of pre eclampsia. If the future studies with 
larger sample show that the treatments of periodontal infections substantially 
reduce the risk of pre eclampsia as is the case with other adverse pregnancy 
outcome then periodontal therapy may be considered a vital part of prenatal care in 
pre-eclamptic patient 
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INTERDISCIPLINARY PREVENTIVE CARE 
         Secondary Level Care        Primordial Level Care 
 
 
 
 
 
 
 
 
Primary Level Care 
 
 
Target Females of child 
bearing age 
Educate screen and send for 
complete dental evaluation 
and treatment 
Target Females of child 
bearing age 
Educate screen and send for 
complete dental evaluation 
based on risk factors 
Dental surgeons 
Obstetricians 
Nursing staff 
Target girls at puberty 
Educate about dental hygiene 
and oral health 
Ensure access to preventive 
dental care 
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PROFORMA 
 
Name:     Last menstrual period: 
Age:      Expected date of delivery: 
I.P.Number: 
Gestational age(weeks):  
Gestational age as per 1
 
st trimester ultra sonogram: 
Socio-Economic Class: 
Educational Qualification: 
Menstrual history: 
Marital history: 
Obstetrics history: 
Medical illness: 
H/o excessive foul smelling vaginal discharge: 
H/o Diabetes/heart disease/hypertension/PIH/multiple gestation: 
H/o any tooth extraction in the past: 
H/o toothache/bleeding from gum 
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Examination 
General Examination: 
Temperature: 
Pulse: 
Blood Pressure: 
Per abdomen Examination: 
Speculum Examination: 
Biochemical and Microbiological Investigations: 
Hb %: 
Platelets: 
Blood Sugar: 
Blood Urea: 
Sr creatinine: 
Liver function test: 
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Sr.uric acid: 
C-Reactive protein Level: 
Urine for Culture: 
KOH whiff test for Bacterial Vaginosis: 
Wet Mount Examination: 
ULTRASONOGRAM: 
Results of Periodontal Examination: 
Periodontitis: Present/Absent 
If present: Localized/Generalized 
Degree of Periodontitis: Mild/Moderate/Severe 
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                                            PATIENT CONSENT FORM  
  STUDY TITLE:  
“ASSOCIATION OF MATERNAL PERIODONTITIS AND RISK OF PRE ECLAMPSIA” 
STUDY CENTRE:   
                                 Institute of Social Obstetrics. Govt.K.G.H. Chennai-5 
PARTICIPANT NAME:                                         AGE:          SEX:            I.D. NO. 
       I confirm that I have understood the purpose of procedure for the above study. I have the 
opportunity to ask the question and all my questions and doubts have been answered to my 
satisfaction. 
       I have been explained about the possible complications that may occur during the procedure. I 
understand that my participation in the study is voluntary and that I am free to withdraw at any time 
without giving any reason. 
        I understand that investigator, regulatory authorities and the ethics committee will not need my 
permission to look at my health records both in respect to the current study and any further research that 
may be conducted in relation to it, even if I withdraw from the study. I understand that my identity will 
not be revealed in any information released to third parties of published, unless as required under the law. 
I agree not to restrict the use of any or results that arise from the study. 
       I hereby consent to participate in this study of “ASSOCIATION OF MATERNAL 
PERIODONTITIS AND RISK OF PRE ECLAMPSIA " 
 
Signature of Investigator                                                       Place: 
                                                                                                     Date: 
Study Investigators Name                                                     Institution: 
Signature / Thumb impression of patient 
                                                          Thanking you,                       
                                                                                             Yours faithfully, 
                                                                                                   Postgraduate 
Guide: 
Prof Dr.Meena umachanders,M.D.,D.G.O , 
Institute of social obstetrics&Govt.KGH, 
Madras Medical College, 
Triplicane, Chennai- 600 005 
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